Grant Status Currently Funded
Division Division of Cancer Control and Population Sciences
Program Epidemiology and Genomics Research Program (EGRP)
Branch Methods and Technologies Branch
PI Name Organization Name Project Title
(Click for Abstract, Pubs, etc.)
Grant Number Initiative
(Click for Funding Announcement)
Awarded Dollars Fiscal Year Abstract Page URL Funding Announcement URL
Backman, Vadim Northwestern University Translating Buccal Nanocytology for Lung Cancer Screening Into Clinical Practice 5R01CA225002-06 PAR15-075 311097 2023
Buas, Matthew Frank Sloan-Kettering Inst Can Research Leveraging Tissue-Specific Regulatory Maps and Network-Assisted Analysis to Identify Novel Genetic Risk Loci for Esophageal Adenocarcinoma 5R03CA262845-03 PAR20-052 90780 2023
Francis, David O. University of Wisconsin-Madison Estimating and Mitigating Thyroid Cancer Overdiagnosis: a Mathematical Modeling Approach 5R01CA251566-04 PA19-056 422335 2023
Hanauer, David Alan University of Michigan at Ann Arbor Advanced Development and Dissemination of Emerse for Cancer Phenotyping From Medical Records 5U24CA204863-05 PAR15-331 681307 2021
Hsu, Li Fred Hutchinson Cancer Center Statistical Methods for Analysis of Tumor Heterogeneity in Genetic Epidemiology 5R01CA189532-09 PA18-484 483940 2022
Jiang, Shu Washington University Dynamic Prediction Incorporating Time-Varying Covariates for the Onset of Breast Cancer 5R37CA256810-02 PAR18-869 374130 2022
Khurana, Ekta Weill Medical Coll of Cornell Univ Computational Methods for Identifying Non-Coding Cancer Drivers 5R01CA218668-05 PA16-160 461451 2022
Khurana, Ekta Weill Medical Coll of Cornell Univ Computational Methods for Identifying Non-Coding Cancer Drivers 3R01CA218668-05S1 PA16-160 9946 2022
Kim, Sungheon Gene Weill Medical Coll of Cornell Univ Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer 5R01CA219964-05 PA16-160 409981 2022
Koyfman, Shlomo Case Western Reserve University Quantitative Histomorphometric Risk Classifier (QUHBIC) in HPV + Oropharyngeal Carcinoma 5R01CA220581-06 PAR15-075 592486 2023
Lieberman, Marya University of Notre Dame Adapting a Point of Use Test Card, the Chemopad, for Protecting Chemotherapy Drug Quality in Sub-Saharan Africa 1U01CA269195-01 CA21-030 485863 2022
Low, Carissa A University of Pittsburgh at Pittsburgh A Mobile Sensing System to Monitor Symptoms During Chemotherapy 5R37CA242545-04 PAR18-869 358675 2022
Ma, Shuangge Yale University Novel Methods for Identifying Genetic Interactions for Cancer Prognosis 5R01CA204120-06 PA20-185 389856 2022
Madabhushi, Anant Emory University An Ai-Enabled Digital Pathology Platform for Multi-Cancer Diagnosis, Prognosis and Prediction of Therapeutic Benefit 1U01CA269181-01 CA21-030 603042 2022
Maley, Carlo Arizona State University-Tempe Campus Modeling Neoplastic Progression in Barrett's Esophagus - Renewal 2 2R01CA140657-11 PA20-185 498943 2023
Pandharipande, Pari Vijay Ohio State University Improving Treatment Selection in Advanced Ovarian Cancer 5R01CA266402-02 PA20-185 532652 2023
Rosner, Bernard A Brigham and Women's Hospital Methodologic Innovations in Cancer Epidemiology 1R01CA272489-01A1 PA20-185 486936 2023
Salipante, Stephen J University of Washington Efficient, Cost-Effective, and Ultrasensitive Sequencing of Somatic Mutations 1R21CA272014-01 CA21-003 181741 2022
Swager, Timothy M Massachusetts Institute of Technology Innovative Droplet Lenses for Nextgen Light Sensors of Biomarkers of Inflammation 5R21CA256081-03 CA20-017 105059 2023
Vanderweele, Tyler Harvard School of Public Health Theory and Methods for Mediation and Interaction 5R01CA222147-05 PA16-160 438224 2022
Verhaak, Roel Gw Jackson Laboratory Characterization of Extrachromosomal Dnas in Tumors Through Computational Analysis of Single-Cell and Bulk Sequencing Data 1R21CA256575-01A1 PAR20-277 478230 2021
Zevallos, Jose P Washington University Development of a Four-Class, Molecular Subtyping Diagnostic for HPV-Negative Head and Neck Cancer 5R01CA211939-05 PAR15-075 497785 2021
Zhang, Xuehong Brigham and Women's Hospital Proteomics Study of Non-Viral Related Hepatocellular Carcinoma Risk 5R21CA238651-02 PA18-678 208492 2021